# Deep Anterior Lamellar Keratoplasty (DALK) Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients

> **NCT01021046** · NA · COMPLETED · sponsor: **Wenzhou Medical University** · enrollment: 78 (estimated)

## Conditions studied

- Glycerin Cryopreserved Acellular Corneal Tissue
- Deep Anterior Lamellar Keratoplasty
- High Risk Keratoplasty

## Interventions

- **PROCEDURE:** DALK using GCCT
- **PROCEDURE:** DALK using FCT

## Key facts

- **NCT ID:** NCT01021046
- **Lead sponsor:** Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 78 (ESTIMATED)
- **Last updated:** 2010-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01021046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01021046, "Deep Anterior Lamellar Keratoplasty (DALK) Using Acellular Corneal Tissue Promotes Corneal Allograft Survival in High Risk Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01021046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*